Series C

Rgenix generates $40m series C
The Rockefeller spinout will use the series C proceeds to advance two cancer drug candidates through early-stage clinical trials.
OmniSci maps out $55m series C
OmniSci, formerly known as MapD and based on research at MIT, has added $55m to its coffers thanks to investors including Nvidia and Verizon, bringing its total funding to $92m.
Fusion pipes in $8m series C
University of Michigan's manufacturing coolant spinout Fusion Coolant Systems has been backed by the institution's Mints fund, taking its total to $9.9m.
Bellen sells investors on series C round
The nine-figure renminbi sum follows a series A round of undisclosed size two years ago that was backed by THG Ventures.
Investors go with gut in $83m UBiome round
Stanford-StartX Fund-backed microbial diagnostics and wellness product developer UBiome has raised $83m in series C funding.
Atreca carries on funding streak
Principia Biopharma primes $86m IPO
Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.
Corporates help plant $150m in Orchard

Other News

SQZ indexes $72m in series C round
Illumina, GV and Orient Life supported a $72m series C round for MIT spinout SQZ Biotechnology, with the money set to fund therapies for solid tumours and autoimmunity.
Investors fork over $30m to Formlabs
The 3D printer developer, spun out of MIT Media Lab, increased its overall funding to $85m in a series C round that will support growth in Asia.
GV eyes Verana in $30m series C
Verana Health, a life sciences product development platform spun out from Stanford and formerly known as DigiSight, has received funding from GV and GE Ventures.
Apeel Sciences attracts $70m
Apeel has taken its total funding to $110m after raising $70m in a series C round led by Viking Global Investors.
Tsingyuan helps Quantapore create new round
The nanopore sequencing platform developer has closed a $15.5m series 3 round backed by Tsingyuan Ventures.

Editor's Picks

Big deal: Touchstone helps inject $73m into Cell Medica
Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.
Kymeta satellites $50m
Kymeta Corporation, a satellite parts manufacturer, raises $50m series C with backing from consortium including multi-university venture fund Osage University Partners.
UC Santa Barbara spin out raises $30m
University of California, Santa Barbara cloud spin out Eucalyptus Systems raises the funds with backing from BV Capital, the former corporate venturing unit of Germany-based media company Bertelsmann.
test reg


Not yet subscribed?

See your subscription offers here